Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting
  • Written by Admin
  • Written date 2019-02-07 09:27:25
  • Inquire 627

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting.

(https://www.edqm.eu/en/groups-experts-and-working-parties)

List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr....